F. Gary Toback
Corporate Officer/Principal chez The University of Chicago
Postes actifs de F. Gary Toback
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| The University of Chicago | Corporate Officer/Principal | 01/01/1985 | - |
Historique de carrière de F. Gary Toback
Anciens postes connus de F. Gary Toback
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
NephRx Corp.
 NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Directeur Technique/Scientifique/R&D | - | - |
Formation de F. Gary Toback
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| New York University | Doctorate Degree |
| Boston University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 5 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
NephRx Corp.
NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Health Technology |
- Bourse
- Insiders
- F. Gary Toback
- Expérience
